Clinical Trials in Minneapolis

Showing 7161-7180 of 11,007 trials

Intralesional Steroids in the Treatment of Alopecia Areata

NCT01898806

This study aims to determine the frequency of response to treatment with 3 concentrations of IL TAC, 2.5mg/ml, 5mg/ml or 10mg/ml as well as the duration of response and incidence of side effects compared to treatment with placebo (sterile saline solution). After the 1st 6 months, nonresponders or partial responders may be treated for 6 months with open label triamcinolone at the dose deemed appropriate by the investigator. The investigators will also perform skin biopsies of the scalp and draw blood at selected time points in order to examine the immunohistochemical/pathological response in scalp hair follicles and the systemic circulation to treatment with IL TAC for alopecia areata.

Alopecia Areata

Columbia University11 participantsStarted Sep 2011

Minneapolis, Minnesota, United States • New York, New York, United States

COMPLETEDNA< 1 mile

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

NCT02002533

This randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy. Sleep disorder counseling may reduce fatigue and insomnia as well as improve the well-being and quality of life in patients with breast cancer who are undergoing chemotherapy.

Sleep DisorderStage IA Breast CancerStage IB Breast Cancer+4 more

Gary Morrow71 participantsStarted Feb 2014

Stanford, California, United States • Decatur, Illinois, United States • Wichita, Kansas, United States +3 more locations

Intralesional Steroids in the Treatment of Alopecia Areata

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Find Trials by Condition in Minneapolis

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Alefacept in Patients With Severe Scalp Alopecia Areata

The Chimerix CMX001 Registry

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

12-Week Study of Plecanatide for CIC (The National CIC3 Study)

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer